Description
HAVRIX SUSP INY AD 1ML JGA PRELL ESTROGENOS CONJUGADOS PRINCIPIO ACTIVO: LEVOFLOXACINO PRINCIPIO ACTIVO: LEVOFLOXACINO GLIVEC® 100 mg es un medicamento oncológico cuyo principio activo es Imatinib Caja C 1 Jeringa Prellenada
HAVRIX SUSP INY AD 1ML JGA PRELL ESTROGENOS CONJUGADOS PRINCIPIO ACTIVO: LEVOFLOXACINO PRINCIPIO ACTIVO: LEVOFLOXACINO GLIVEC® 100 mg es un medicamento oncológico cuyo principio activo es Imatinib Caja C 1 Jeringa Prellenada
Ask which channel manages changes for an order placed there. Ask whether an advertised benefit applies to your intended channel.
Look for current guidance rather than relying only on saved instructions. If the change is important, request a concise comparison from the seller.
Review what you would need to do if you accept the proposal. Ask how completion of the resolution will be confirmed.
US$ 5495.00
US$ 9995.00
US$ 12495.00
US$ 5495.00
US$ 12495.00
US$ 4995.00
US$ 4995.00